Table of Contents
PART 1: Global Cord Blood Banking Industry - Market Overview & Outlook
As of 2013, the cord blood banking industry is one of the fastest growing industries in the world. In 2005, there were only 23 active cord blood banks worldwide; today there are 485. This represents a 21-fold increase (2,100%) in industry growth, in less than a ten-year period.
Furthermore, stem cells derived from umbilical blood have been used in more than 30,000 transplants worldwide to treat a wide range of blood diseases, genetic and metabolic disorders, immunodeficiencies and various forms of cancer. Cord blood banks now exist in nearly every developed country, as well as within several developing nations.
However, there is still significant variation within the industry. First, there is the divide between private and public cord blood banking, in which private companies serve individual families, while public banks serve the broader public. Additionally, some cord blood banks receive only units from nearby hospitals and birthing centers, while others allow mail-in units from a diverse geographic region. There is also variation in the services offered by private cord blood banks, with cord tissue storage emerging as a commercial service in 2008, when a Taiwanese company, HealthBanks Biotech Company Ltd., began offering the service. Since then, the trend of cord tissue storage has had a significant impact on the cord blood banking industry, as 23 companies now offer private cord tissue storage services worldwide. Finally, there is significant variation in the quality, pricing, and guarantees promised by cord blood banks.
This section of the report considers the impact of historical events, the importance of key findings and discoveries on market conditions, and rapidly changing aspects of the industry. It is a roadmap of where the cord blood banking industry has been, what has shaped it, and where it is going. With an understanding of these market conditions, the subsequent sections of this report become “rooted” and relevant.
PART 2: Expansion & Growth – Trailing 12-Month Analysis and Future Projections
While the last section investigated where the global cord blood banking industry has been and what has shaped it, this section explores where it is now and what you can anticipate for the near-term future. It provides a detailed assessment of current market conditions and near-term projections.
Regional similarities and differences are presented, as following global trends in cord blood banking provides a strategic advantage. Due to varying regulatory, cultural, technical, and medical differences between geographic regions of the world, successful trends that emerge in one region can often be modeled in another.
This section also explores key industry trends for the global cord blood banking industry, including rates of cord blood storage, scientific publication rates, grant rates, patent rates, and much more. Barriers to entering the marketplace are also considered, as are novel tactics for driving company growth. Finally, differences in pricing, technical variables, and corporate variables are explored, allowing cord blood banks to understand how they compare relative to the competition.
Furthermore, over the past 12 months, the cord blood banking industry has expanded through double digit growth, due to new entrants in the cord blood industry and revenue growth at existing operations. Deeper analysis reveals that most existing cord blood banks follow a bi-modal distribution, either experiencing flat-line growth (less than 3% per annum) or substantively building revenue (25% or more per annum).
To guide industry competitors, this section of the report considers the questions:
• What factors are causing a substantial number of new cord blood banks to open up business?
• What will be the effect of these new entrants to the cord blood banking industry for existing competitors?
• How can existing competitors maintain a position of dominance in the industry among this trend?
While a similar bimodal distribution existed in the prior 12 month period (trailing 12 to 24 months), the peaks have continued to separate over the past 12 months, with the average flat-growth company staying stagnant and the average fast-growth company substantially increasing its per annum growth rate.
This trend indicates an increasing shift in dominance toward fast-growth companies, which begs the questions:
• What are the differences between the cord blood banks that are experiencing flat-line growth, versus those that have substantively building revenue?
• Why are the fast-growth companies continuing to increase their dominance relative to the flat-growth companies?
In summary, this section is dedicated to identifying, quantifying, and extrapolating global industry trends, for the purpose of giving meaningful projections for the future.
It is your guide to understanding expansion and growth within the global cord blood banking industry.
PART 3: Parent Survey – Continuing to Grow by Listening to Expectant Parents
To recap, the first section of the report established where the cord blood banking industry has been and what has shaped it. The second section explored where it is now and what you should anticipate for the near-term future, providing a detailed assessment of current market conditions and near-term projections. This final section of the report is now your roadmap to the future. It is your guide to taking strategic action and controlling your competitive position as a global cord blood bank.
This section contains findings from a detailed parent survey that reveals how expectant parents worldwide learn about cord blood banking, think about the process, and make key decisions. This survey is your insight into the minds of your prospective clients. Use it to claim a powerful control of your ability to sell your services more effectively.
You can use the findings revealed here to:
• Alter the way you position your products
• Understand why parents bank publicly, privately, or not at all
• Communicate successfully with parents
• Effectively educate parents
• Prioritize your advertising budget
• Sell your services more effectively
In summary, this section is your guide to growing, expanding, and profiting, by listening to the needs of your clients – expectant parents.
About the Expanded 2013 Version:
This expanded 2013 version of the report considers the impact of historical events, the importance of key findings and discoveries on market conditions, and rapidly changing aspects of the industry. Readers of the report are taken through the process of understanding where the cord blood banking industry has been and what has shaped it, where it is now and what should be anticipated for the near-term future.
This expanded 2013 version of the report reveals up-to-date strategies for dominating the cord blood banking industry, investigates tactics for global expansion, and identifies patterns in regional dominance– which is particularly valuable because there has been rapid industry growth within specific regions of the world.
Finally, it gives perspective into the experience and decision-making process of prospective clients, delivering an insider’s understanding of how to more effectively communicate and position cord blood banking services to expectant parents: it includes a 2013 Global Survey of Expectant Parents that explores how cord blood banks can best communicate with and market services to potential clients and features an extensive Appendix. The Appendix includes a full list of "Existing Conditions Treatable with Cord Blood Transplant," a "Global List of Cord Blood Banks, 2013," an overview of "AABB Accredited Cord Blood Banks Worldwide, 2013,” and more.
The report is designed to guide decision-making of global cord blood banks, as well as to advise companies investing in the cord blood banking sector, including venture capital funds and private investors. It differs from the ""Complete 2012-13 U.S. Cord Blood Banking Industry Report"" (details here) in that it is a strategic overview of how to profit from the global cord blood banking market, rather than from the U.S. market alone.
In summary, this industry report is a strategic overview of how to profit from global growth in cord blood banking and provides insights necessary to take decisive, strategic action.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
Animal Blood Plasma Products and Derivatives Market (Derivatives Type - Immunoglobulin, Fibrinogen, Serum Albumin, and Fetal Bovine Serum; Application - Cell Culture Media, Food Industry, Pharmaceutical ...
The global apheresis market is projected to reach USD 2.06 billion by 2021, at a CAGR of 7.7% during the forecast period of 2016 to 2021. Growth in this market is majorly driven by the rising prevalence ...
Blood collection, processing, management devices & consumables are class of medical devices used for collecting the whole blood from the donor, segregating the collected blood into blood components like ...